RxDoctor Payments Data

Andrew Irons, PA

Physician Assistant · Burlington, NCNPI 1003067034

Payments from drug & device makers

$2,439in general payments, 2019–2025

Across 125 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$816
  • Harmony Biosciences LLC$552
  • Axsome Therapeutics, Inc.$152
  • UCB, Inc.$144
  • Boston Scientific$136
  • AbbVie$128
  • plus $511 from 16 others

What the payments were for

  • Food & beverage$2,20290%
  • Education$23710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,439 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$44,067
Medicare patients
435
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sodium Oxybate12$214,729
NeuproRotigotine33$34,980
Topiramate ErTopiramate22$22,551
SunosiSolriamfetol Hcl18$14,692
BelsomraSuvorexant19$8,212
ConcertaMethylphenidate Hcl11$4,580
Gabapentin394$4,488
Levetiracetam77$3,295
Pramipexole DihydrochloridePramipexole Di-Hcl162$3,274
Mirtazapine97$3,262
Ropinirole ErRopinirole Hcl23$2,332
Armodafinil32$1,952
Clonazepam174$1,534
Modafinil38$1,526
Ropinirole Hcl100$1,231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Neupro$144$34,98033 claims
Axsome Therapeutics, Inc.Sunosi$152$14,69218 claims
MerckBelsomra$33$8,21219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Burlington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →